Treatment Outcomes of Maxillectomy for Squamous Cell Carcinomas of the Maxillary Sinus

상악동 편평세포암종에 대한 상악절제술의 치료 결과

  • Jeong Han-Sin (Department of Otorhinolaryngology-Head and Neck Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center) ;
  • Son Young-Ik (Department of Otorhinolaryngology-Head and Neck Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center) ;
  • Chung Man-Ki (Department of Otorhinolaryngology-Head and Neck Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center) ;
  • Min Jin-Young (Department of Otorhinolaryngology-Head and Neck Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center) ;
  • Oh Jae-Won (Department of Otorhinolaryngology-Head and Neck Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center) ;
  • Hong Sang-Duk (Department of Otorhinolaryngology-Head and Neck Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center) ;
  • Lee Hyun-Seok (Department of Otorhinolaryngology-Head and Neck Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center) ;
  • Baek Chung-Hwan (Department of Otorhinolaryngology-Head and Neck Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center)
  • 정한신 (성균관대학교 의과대학 삼성서울병원 이비인후과학교실) ;
  • 손영익 (성균관대학교 의과대학 삼성서울병원 이비인후과학교실) ;
  • 정만기 (성균관대학교 의과대학 삼성서울병원 이비인후과학교실) ;
  • 민진영 (성균관대학교 의과대학 삼성서울병원 이비인후과학교실) ;
  • 오재원 (성균관대학교 의과대학 삼성서울병원 이비인후과학교실) ;
  • 홍상덕 (성균관대학교 의과대학 삼성서울병원 이비인후과학교실) ;
  • 이현석 (성균관대학교 의과대학 삼성서울병원 이비인후과학교실) ;
  • 백정환 (성균관대학교 의과대학 삼성서울병원 이비인후과학교실)
  • Published : 2006.05.01

Abstract

Background and Objectives: Maxillectomy is the mainstay of treatment for malignant tumors of the maxillary sinus(MS). Nevertheless, few have been reported on the surgical outcomes of maxillectomy for malignant tumors of MS in Korean literature. Based on our clinical experience, the authors aimed to present the treatment outcomes of maxillectomy for squamous cell carcinomas(SCC) of MS. Subjects and Methods: We reviewed the medical records of 26 cases of maxillectomies with see of MS, who were treated from 1995 to 2004 at Samsung Medical Center. Most patients(73.1%) were locally advanced stage(T3 or T4a) at initial presentation. Total maxillectomy was performed in 18 cases, which is the most frequent procedure(69.2%). We analyzed the treatment outcomes of see of MS and several variables includeing tumor stage and resection margin to identify predictors for treatment failure after maxillectomy. Follow-up duration ranged from 7 to 89 months with a mean of 33 months. Results: Treatment failure occurred in 7 cases(26.9%), among which 3 were salvaged. Three of 26 maxillectomies(11.5%) showed the positive or close(less than 5mm) resection margin in their posterior resection sites; however it did not coincide with the site of recurrence after radiation therapy. Among patients who had been followed up for more than 6 months, disease-free 3 year survival rate was 100.0% in T1 and T2, 76.2% in T3, 60% in T4a, and 69.6% in total. Conclusion: Even though most of see of MS were detected at locally advanced stage, maxillectomy with or without postoperative radiation therapy for resectable MS see(T1-T4a) provided the acceptable treatment outcome(70%, 3Y disease-free survival rate).

Keywords

References

  1. Stern SJ, Goepfert H, Clayman G, et al: Squamous cell carcinoma of the maxillary sinus. Arch Otolaryngol Head Neck Surg. 1993;119:964-969 https://doi.org/10.1001/archotol.1993.01880210052008
  2. Dulguerov P, Jacobsen MS, Allal AS, Lehmann W, Calcaterra T: Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Cancer. 2001; 92:3012-3029 https://doi.org/10.1002/1097-0142(20011215)92:12<3012::AID-CNCR10131>3.0.CO;2-E
  3. Hayashi T, Nonaka S, Bandoh N, Kobayashi Y, Imada M, Harabuchi Y: Treatment outcome of maxillary sinus squamous cell carcinoma. Cancer. 2001;92:1495-1503 https://doi.org/10.1002/1097-0142(20010915)92:6<1495::AID-CNCR1474>3.0.CO;2-P
  4. Spiro RH, Strong EW, Shah JP: Maxillectomy and its classification. Head Neck. 1997;19:309-314 https://doi.org/10.1002/(SICI)1097-0347(199707)19:4<309::AID-HED9>3.0.CO;2-4
  5. Giri SP, Reddy EK, Gemer LS, Krishnan L, Smalley SR, Evans RG: Management of advanced squamous cell carcinomas of the maxillary sinus. Cancer. 1992;69:657-661 https://doi.org/10.1002/1097-0142(19920201)69:3<657::AID-CNCR2820690310>3.0.CO;2-7
  6. Nishino H, Miyata M, Morita M, Ishikawa K, Kanazawa T, Ichimura K: Combined therapy with conservative surgery, radiotherapy, and regional chemotherapy for maxillary sinus carcinoma. Cancer. 2000;89:1925-1932 https://doi.org/10.1002/1097-0142(20001101)89:9<1925::AID-CNCR8>3.3.CO;2-8
  7. Kondo M, Inuyama Y, Ando Y, et al: Patterns of relapse of squamous cell carcinoma of the maxillary sinus. Cancer. 1984;53: 2206-2210 https://doi.org/10.1002/1097-0142(19840515)53:10<2206::AID-CNCR2820531034>3.0.CO;2-J
  8. Yao K, Takahashi H, Inagi K, et al: Treatment of maxillary sinus carcinoma: clinical results using the Kitasato modality. Acta Otolaryngol Suppl. 2002:15-19
  9. Lore JM, Jr: Partial and radical maxillectomy. Otolaryngol Clin North Am. 1976;9:255-267
  10. Jiang GL, Ang KK, Peters LJ, Wendt CD, Oswald MJ, Goepfert H: Maxillary sinus carcinomas: natural history and results of postoperative radiotherapy. Radiother Oncol. 1991;21:193-200 https://doi.org/10.1016/0167-8140(91)90037-H
  11. Lavertu P, Roberts JK, Kraus DH, et al: Squamous cell carcinoma of the paranasal sinuses: the Cleveland Clinic experience 1977-1986. Laryngoscope. 1989;99:1130-1136
  12. Yucel A, Cinar C, Aydin Y, et al: Malignant tumors requiring maxillectomy. J Craniofac Surg. 2000;11:418-429 https://doi.org/10.1097/00001665-200011050-00003
  13. Choi EC, Choi YS, Kim CH, et al: Surgical outcome of radical maxillectomy in advanced maxillary sinus cancers. Yonsei Med. J 2004;45:621-628 https://doi.org/10.3349/ymj.2004.45.4.621
  14. Stem SJ, Goepfert H, Clayman G, Byers R, Wolf P: Orbital preservation in maxillectomy. Otolaryngol Head Neck Surg. 1993; 109:111-115 https://doi.org/10.1177/019459989310900120
  15. Myers LL, Nussenbaum B, Bradford CR, Teknos TN: Esclamado RM, Wolf GT. Paranasal sinus malignancies: an 18-year single institution experience. Laryngoscope. 2002;112:1964-1969 https://doi.org/10.1097/00005537-200211000-00010
  16. Lindeman P, Eklund U, Petruson B: Survival after surgical treatment in maxillary neoplasms of epithelial origin. J Laryngol Otol. 1987;101:564-568 https://doi.org/10.1017/S0022215100102257
  17. Yoshimura R, Shibuya H, Ogura I, et al: Trimodal combination therapy for maxillary sinus carcinama. Int J Radiat Oncol Biol Phys. 2002;53:656-663 https://doi.org/10.1016/S0360-3016(02)02771-2
  18. Blanco AI, Chao KS, Ozyigit G, et al: Carcinoma of paranasal sinuses: long-term outcomes with radiotherapy. Int J Radiat Oncol Biol Phys. 2004;59:51-58 https://doi.org/10.1016/j.ijrobp.2003.09.101